KEGG   DRUG: D03285Help
Entry
D03285                      Drug                                   

Name
Diphenhydramine tannate (JP16);
Restamin A (TN)
Activity
Antihistaminic
Remark
Therapeutic category: 
ATC code: 
Target
H1-receptor antagonist [HSA:3269] [KO:K04149]
  Pathway
hsa04020  Calcium signaling pathway
hsa04080  Neuroactive ligand-receptor interaction  
 
Metabolism
Enzyme: CYP2D6 [HSA:1565]
Interaction
CYP inhibition: CYP2D6 [HSA:1565]
Drug interaction
Structure map
Hypnotics
Histamine H1 receptor antagonists
Brite
Therapeutic category of drugs in Japan [BR:br08301]
 4  Agents affecting cellular function
  44  Allergic agents
   441  Antihistamines
    4411  Diphenhydramines
     D03285  Diphenhydramine tannate (JP16)
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 D DERMATOLOGICALS
  D04 ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
   D04A ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
    D04AA Antihistamines for topical use
     D04AA32 Diphenhydramine
      D03285  Diphenhydramine tannate (JP16)
 R RESPIRATORY SYSTEM
  R06 ANTIHISTAMINES FOR SYSTEMIC USE
   R06A ANTIHISTAMINES FOR SYSTEMIC USE
    R06AA Aminoalkyl ethers
     R06AA02 Diphenhydramine
      D03285  Diphenhydramine tannate (JP16)
USP drug classification [BR:br08302]
 Antiemetics
  Antiemetics, Other
   Diphenhydramine
    D03285  Diphenhydramine tannate (JP16)
 Antiparkinson Agents
  Anticholinergics
   Diphenhydramine
    D03285  Diphenhydramine tannate (JP16)
 Respiratory Tract/Pulmonary Agents
  Antihistamines
   Diphenhydramine
    D03285  Diphenhydramine tannate (JP16)
Target-based classification of drugs [BR:br08310]
 G Protein-coupled receptors
  Rhodopsin family
   Histamine
    H1-receptor [HSA:3269] [KO:K04149]
     Diphenhydramine [ATC:D04AA32 R06AA02]
      D03285  Diphenhydramine tannate (JP16)
BRITE hierarchy
Other DBs
PubChem: 
DrugBank: 

» Japanese version   » Back

DBGET integrated database retrieval system